Arcturus Therapeutics Holdings Inc.ARCTNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P15
Within normal range
vs 3Y Ago
-0.3x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -114.29% |
| Q3 2025 | -44.12% |
| Q2 2025 | 34.62% |
| Q1 2025 | 53.15% |
| Q4 2024 | -326.92% |
| Q3 2024 | 59.38% |
| Q2 2024 | 36.00% |
| Q1 2024 | -212.50% |
| Q4 2023 | 47.54% |
| Q3 2023 | 69.19% |
| Q2 2023 | -203.66% |
| Q1 2023 | -56.88% |
| Q4 2022 | 440.77% |
| Q3 2022 | -58.54% |
| Q2 2022 | 58.38% |
| Q1 2022 | -34.01% |
| Q4 2021 | 28.29% |
| Q3 2021 | 0.97% |
| Q2 2021 | 3.72% |
| Q1 2021 | -80.67% |
| Q4 2020 | -29.35% |
| Q3 2020 | -67.27% |
| Q2 2020 | 17.91% |
| Q1 2020 | 11.84% |
| Q4 2019 | -35.71% |
| Q3 2019 | -751.06% |
| Q2 2019 | 90.32% |
| Q1 2019 | -580.00% |
| Q4 2018 | 76.19% |
| Q3 2018 | 57.58% |
| Q2 2018 | -50.00% |
| Q1 2018 | -500.00% |
| Q4 2017 | 84.93% |
| Q3 2017 | 30.48% |
| Q2 2017 | -17.98% |
| Q1 2017 | 41.06% |
| Q4 2016 | 23.74% |
| Q3 2016 | -34.69% |
| Q2 2016 | -13.95% |
| Q1 2016 | 9.15% |